Your browser doesn't support javascript.
loading
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases.
Rakha, Emad A; Miligy, Islam M; Quinn, Cecily M; Provenzano, Elena; Shaaban, Abeer M; Marchiò, Caterina; Toss, Michael S; Gallagy, Grace; Murray, Ciara; Walshe, Janice; Katayama, Ayaka; Eldib, Karim; Badr, Nahla; Tanchel, Bruce; Millican-Slater, Rebecca; Purdie, Colin; Purnell, Dave; Pinder, Sarah E; Ellis, Ian O; Lee, Andrew H S.
Affiliation
  • Rakha EA; Department of Histopathology, Nottingham University Hospitals, Nottingham, UK. emad.rakha@nottingham.ac.uk.
  • Miligy IM; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK. emad.rakha@nottingham.ac.uk.
  • Quinn CM; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt. emad.rakha@nottingham.ac.uk.
  • Provenzano E; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.
  • Shaaban AM; Histopathology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
  • Marchiò C; Histopathology, Breast Check, Irish National Breast Screening Programme and St. Vincent's University Hospital, Dublin, Ireland.
  • Toss MS; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Gallagy G; Queen Elizabeth Hospital Birmingham and Institute of Cancer and Genomic Sciences, The University of Birmingham, Birmingham, UK.
  • Murray C; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Walshe J; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Katayama A; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.
  • Eldib K; Discipline of Pathology, School of Medicine, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.
  • Badr N; Histopathology, Breast Check, Irish National Breast Screening Programme and St. Vincent's University Hospital, Dublin, Ireland.
  • Tanchel B; Histopathology, Breast Check, Irish National Breast Screening Programme and St. Vincent's University Hospital, Dublin, Ireland.
  • Millican-Slater R; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.
  • Purdie C; Department of Histopathology, Nottingham University Hospitals, Nottingham, UK.
  • Purnell D; Queen Elizabeth Hospital Birmingham and Institute of Cancer and Genomic Sciences, The University of Birmingham, Birmingham, UK.
  • Pinder SE; Queen Elizabeth Hospital Birmingham and Institute of Cancer and Genomic Sciences, The University of Birmingham, Birmingham, UK.
  • Ellis IO; Department of Histopathology, St James's University Hospital, Leeds, UK.
  • Lee AHS; Department of Breast Pathology, Ninewells Hospital and Medical School, Dundee, UK.
Br J Cancer ; 124(11): 1836-1842, 2021 05.
Article in En | MEDLINE | ID: mdl-33762723
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Gene Dosage Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Gene Dosage Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom